Thomson Medical Group Limited

SGX:A50 Stock Report

Market Cap: S$1.4b

Thomson Medical Group Future Growth

Future criteria checks 4/6

Thomson Medical Group is forecast to grow earnings and revenue by 39.6% and 14.3% per annum respectively. EPS is expected to grow by 43.2% per annum. Return on equity is forecast to be 7.3% in 3 years.

Key information

39.6%

Earnings growth rate

43.2%

EPS growth rate

Healthcare earnings growth17.3%
Revenue growth rate14.3%
Future return on equity7.3%
Analyst coverage

Low

Last updated27 Feb 2024

Recent future growth updates

Recent updates

Calculating The Fair Value Of Thomson Medical Group Limited (SGX:A50)

Apr 01
Calculating The Fair Value Of Thomson Medical Group Limited (SGX:A50)

Should You Think About Buying Thomson Medical Group Limited (SGX:A50) Now?

Dec 16
Should You Think About Buying Thomson Medical Group Limited (SGX:A50) Now?

Here's Why Thomson Medical Group (SGX:A50) Has A Meaningful Debt Burden

Aug 31
Here's Why Thomson Medical Group (SGX:A50) Has A Meaningful Debt Burden

We Ran A Stock Scan For Earnings Growth And Thomson Medical Group (SGX:A50) Passed With Ease

Apr 24
We Ran A Stock Scan For Earnings Growth And Thomson Medical Group (SGX:A50) Passed With Ease

Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet

Mar 27
Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet

Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet

Nov 22
Thomson Medical Group (SGX:A50) Has A Pretty Healthy Balance Sheet

Should You Be Adding Thomson Medical Group (SGX:A50) To Your Watchlist Today?

Sep 30
Should You Be Adding Thomson Medical Group (SGX:A50) To Your Watchlist Today?

Market Participants Recognise Thomson Medical Group Limited's (SGX:A50) Earnings

Sep 03
Market Participants Recognise Thomson Medical Group Limited's (SGX:A50) Earnings

These 4 Measures Indicate That Thomson Medical Group (SGX:A50) Is Using Debt Reasonably Well

Feb 26
These 4 Measures Indicate That Thomson Medical Group (SGX:A50) Is Using Debt Reasonably Well

We Think Thomson Medical Group (SGX:A50) Can Stay On Top Of Its Debt

Oct 21
We Think Thomson Medical Group (SGX:A50) Can Stay On Top Of Its Debt

We Think Thomson Medical Group (SGX:A50) Has A Fair Chunk Of Debt

Mar 27
We Think Thomson Medical Group (SGX:A50) Has A Fair Chunk Of Debt

Eng Lim Just Bought A Sprinkling of Shares In Thomson Medical Group Limited (SGX:A50)

Feb 20
Eng Lim Just Bought A Sprinkling of Shares In Thomson Medical Group Limited (SGX:A50)

Should You Take Comfort From Insider Transactions At Thomson Medical Group Limited (SGX:A50)?

Jan 27
Should You Take Comfort From Insider Transactions At Thomson Medical Group Limited (SGX:A50)?

Reflecting on Thomson Medical Group's (SGX:A50) Share Price Returns Over The Last Year

Dec 23
Reflecting on Thomson Medical Group's (SGX:A50) Share Price Returns Over The Last Year

Is Thomson Medical Group (SGX:A50) Using Too Much Debt?

Nov 27
Is Thomson Medical Group (SGX:A50) Using Too Much Debt?

Earnings and Revenue Growth Forecasts

SGX:A50 - Analysts future estimates and past financials data (SGD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/2026504431001072
6/30/2025468371091102
6/30/202440420-374892
12/31/202334516155173N/A
9/30/202335326115131N/A
6/30/2023361377689N/A
3/31/20233715083102N/A
12/31/20223796491115N/A
9/30/20223595978104N/A
6/30/2022339546593N/A
3/31/2022304364875N/A
12/31/2021269193058N/A
9/30/2021255162760N/A
6/30/2021240142461N/A
3/31/2021228-381453N/A
12/31/2020215-89545N/A
9/30/2020215-94250N/A
6/30/2020216-99-255N/A
12/31/201923011168N/A
9/30/201922722362N/A
6/30/201922271749N/A
3/31/201921891948N/A
12/31/2018216111641N/A
9/30/2018212101444N/A
6/30/2018208142351N/A
3/31/2018204152347N/A
12/31/2017201162752N/A
8/31/201719933N/A49N/A
8/31/201619327N/A44N/A
8/31/201517725N/A41N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A50's forecast earnings growth (39.6% per year) is above the savings rate (2.1%).

Earnings vs Market: A50's earnings (39.6% per year) are forecast to grow faster than the SG market (6.7% per year).

High Growth Earnings: A50's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: A50's revenue (14.3% per year) is forecast to grow faster than the SG market (3.6% per year).

High Growth Revenue: A50's revenue (14.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: A50's Return on Equity is forecast to be low in 3 years time (7.3%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.